Congressional Medicaid advisers voted unanimously Thursday (April 11) to recommend removing the drug-rebate cap in Medicaid, a recommendation that also is backed by the Trump administration and a key House Republican, after several MACPAC members grew comfortable with removing the cap since initially expressing doubts at a March meeting. Prices for 18.5% of brand drugs have risen quickly enough to hit the cap, according to research by the Medicaid and CHIP Payment and Access Commission (MACPAC), so makers of those...